Key Takeaways

  • IQity and Sightpath Medical are partnering to combine next-generation ophthalmic diagnostic and surgical technologies with a nationwide service and support infrastructure serving more than 1,000 facilities
  • The collaboration aims to accelerate market adoption of IQity’s upcoming innovations while ensuring dependable logistics, installation, and operational support for providers nationwide

IQity announced a strategic partnership with Sightpath Medical to create a comprehensive solution for surgeons and facilities seeking improved outcomes, greater efficiency, and lower operational costs, the companies announced. 

Financial terms of the deal were not disclosed. 

IQity’s integrated platform is designed to streamline and enhance the full ophthalmic workflow. The company expects to launch its first three flagship technologies in the near future:

  • IQ-SurgiView – A digital robotic surgical microscope featuring AI-assisted visualization
  • IQ-Meter – An all-in-one diagnostics and laser treatment device designed for premium lens surgery
  • IQ-Flow – A handheld, triple-action endoscopic cyclophotocoagulation (ECP) device intended to redefine glaucoma treatment

Through the partnership, these technologies will be supported by Sightpath Medical’s nationwide infrastructure, which currently serves more than 1,000 surgical facilities across all 50 states. Sightpath’s operational platform includes highly trained technicians and clinical staff, along with a mobile warehouse system stocked with cataract, glaucoma, and retina surgical equipment and supplies.

The collaboration is expected to provide physicians and facilities with enhanced reliability and service continuity, including Sightpath’s well-known emergency backup support capabilities.

“At IQity, our mission is to address the most pressing challenges in ophthalmology with technology designed to deliver superior visual outcomes, greater efficiency, and lower cost,” said Luke Clauson, CEO of IQity. “This partnership with Sightpath is a direct expression of that mission. We are bringing revolutionary ophthalmic technology to market through a service infrastructure that surgeons already trust.”

Yousuf Kalifa, MD, said the partnership represents a major step forward for the industry.

“By fusing IQity’s cutting-edge diagnostics and surgical interventions with Sightpath’s legendary operational efficiency, we are redefining the standard of ophthalmic care,” Dr. Kalifa said. “This partnership bridges the gap between the innovation pipeline and the operating room, delivering nimble, state-of-the-art technology through a proven framework of clinical excellence.”

“We are excited about the opportunity to work with the IQity team and leverage our expertise in logistics, installation and service to provide comprehensive inventory management and ongoing operational support as they introduce innovative technologies to the marketplace,” said Dan Robins, Chief Operating Officer at Finnitiv Health, Sightpath Medical’s parent company.

The partnership is effective immediately. For more information about IQity’s integrated ophthalmic platform, visit www.iqity.tech.